{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:13:25Z","timestamp":1790957605784,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Nitric oxide (NO) is crucial for endothelial dysfunction and its deficiency is linked to cardiovascular disease (CVD) and impaired kidney function. While research has explored NO metabolism in individuals with kidney disease, diabetes mellitus (DM) or CVD, the relationship in healthy individuals remains unclear. Studies using estimated glomerular filtration rate (eGFR) for kidney function may introduce non-GFR-related factors, confounding the results. We investigated the association between NO-related biomarkers and CVD outcomes in a healthy population, comparing adjustments using eGFR and measured GFR (mGFR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This 14-year longitudinal study evaluated 1575 healthy, middle-aged participants without pre-existing DM, CVD or kidney disease in the Renal Iohexol Clearance Survey (RENIS). Cox regression models assessed the effects of asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, citrulline and ornithine levels on CVD incidence and all-cause mortality. Analyses were adjusted for GFR using mGFR by iohexol clearance or eGFR based on serum creatinine (eGFRcrea) or cystatin C (eGFRcys).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Elevated ADMA levels were associated with incident CVD across all GFR adjustment methods, with a hazard ratio (HR) of 1.21 [95% confidence interval (CI) 1.06\u20131.38] for mGFR. SDMA was associated with CVD when adjusting for eGFRcrea [HR 1.19 (95% CI 1.03\u20131.38)], not with mGFR or eGFRcys. Through all GFR methods, higher citrulline levels consistently correlated with CVD [HR 1.17 (95% CI 1.03\u20131.33) for mGFR]. No biomarkers were linked to all-cause mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In a healthy population, ADMA and citrulline were associated with incident CVD, regardless of the GFR adjustment method, while the association of SDMA depended on the method used.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf181","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T11:37:14Z","timestamp":1749814634000},"source":"Crossref","is-referenced-by-count":2,"title":["Asymmetric dimethylarginine and citrulline are risk factors for cardiovascular disease independently of both estimated and measured GFR"],"prefix":"10.1093","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1652-4864","authenticated-orcid":false,"given":"Nikoline B","family":"Rinde","sequence":"first","affiliation":[{"name":"Metabolic and Renal Research Group, UiT The Arctic University of Norway , Troms\u00f8 ,","place":["Norway"]},{"name":"Section of Nephrology, University Hospital of North Norway , Troms\u00f8 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toralf","family":"Melsom","sequence":"additional","affiliation":[{"name":"Metabolic and Renal Research Group, UiT The Arctic University of Norway , Troms\u00f8 ,","place":["Norway"]},{"name":"Section of Nephrology, University Hospital of North Norway , Troms\u00f8 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Martin","family":"Fuskev\u00e5g","sequence":"additional","affiliation":[{"name":"University Hospital of North Norway Division of Diagnostic Services, Department of Laboratory Medicine, , Troms\u00f8 ,","place":["Norway"]},{"name":"UiT The Arctic University of Norway Department of Clinical Medicine, , Troms\u00f8 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5837-2806","authenticated-orcid":false,"given":"Bj\u00f8rn O","family":"Eriksen","sequence":"additional","affiliation":[{"name":"Metabolic and Renal Research Group, UiT The Arctic University of Norway , Troms\u00f8 ,","place":["Norway"]},{"name":"Section of Nephrology, University Hospital of North Norway , Troms\u00f8 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Viljar","family":"Norvik","sequence":"additional","affiliation":[{"name":"Metabolic and Renal Research Group, UiT The Arctic University of Norway , Troms\u00f8 ,","place":["Norway"]},{"name":"Section of Nephrology, University Hospital of North Norway , Troms\u00f8 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"2025071004061739300_bib1","volume-title":"Global status report on noncommunicable diseases 2010","author":"World Health Organization","year":"2011"},{"key":"2025071004061739300_bib2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2025071004061739300_bib3","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025071004061739300_bib4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/heart.85.3.342","article-title":"Endothelial function and nitric oxide: clinical relevance","volume":"85","author":"Vallance","year":"2001","journal-title":"Heart"},{"key":"2025071004061739300_bib5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1567-5688(03)00030-8","article-title":"ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease","volume":"4","author":"B\u00f6ger","year":"2003","journal-title":"Atheroscler Suppl"},{"key":"2025071004061739300_bib6","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.321752","article-title":"Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease","volume":"132","author":"Baaten","year":"2023","journal-title":"Circ Res"},{"key":"2025071004061739300_bib7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mam.2004.09.003","article-title":"The role of nitric oxide in cardiovascular diseases","volume":"26","author":"Naseem","year":"2005","journal-title":"Mol Aspects Med"},{"key":"2025071004061739300_bib8","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s11357-013-9523-1","article-title":"Asymmetric dimethylarginine predicts survival in the elderly","volume":"35","author":"Pizzarelli","year":"2013","journal-title":"Age (Dordr)"},{"key":"2025071004061739300_bib9","doi-asserted-by":"publisher","first-page":"e96875","DOI":"10.1371\/journal.pone.0096875","article-title":"Incidence of all-cause and cardiovascular mortality predicted by symmetric dimethylarginine in the population-based study of health in Pomerania","volume":"9","author":"Schwedhelm","year":"2014","journal-title":"PLoS One"},{"key":"2025071004061739300_bib10","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1161\/ATVBAHA.113.301219","article-title":"Symmetrical dimethylarginine predicts mortality in the general population","volume":"33","author":"Gore","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025071004061739300_bib11","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.108.838268","article-title":"Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community","volume":"119","author":"B\u00f6ger","year":"2009","journal-title":"Circulation"},{"key":"2025071004061739300_bib12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/ATVBAHA.107.156596","article-title":"Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women","volume":"28","author":"Leong","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025071004061739300_bib13","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"2025071004061739300_bib14","doi-asserted-by":"publisher","first-page":"11288","DOI":"10.3390\/ijms130911288","article-title":"Asymmetric dimethylarginine, endothelial dysfunction and renal disease","volume":"13","author":"Ald\u00e1miz-Echevarr\u00eda","year":"2012","journal-title":"Int J Mol Sci"},{"key":"2025071004061739300_bib15","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"2025071004061739300_bib16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrneph.2011.31","article-title":"The role of asymmetric and symmetric dimethylarginines in renal disease","volume":"7","author":"Schwedhelm","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"2025071004061739300_bib17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.atherosclerosis.2008.10.040","article-title":"Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population","volume":"205","author":"Kiechl","year":"2009","journal-title":"Atherosclerosis"},{"key":"2025071004061739300_bib18","doi-asserted-by":"publisher","first-page":"e0165811","DOI":"10.1371\/journal.pone.0165811","article-title":"Asymmetric and symmetric dimethylarginine as risk markers for total mortality and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies","volume":"11","author":"Schlesinger","year":"2016","journal-title":"PLoS One"},{"key":"2025071004061739300_bib19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00392-017-1172-4","article-title":"Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease","volume":"107","author":"Emrich","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"2025071004061739300_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nephro.2007.02.002","article-title":"The past, presence and future of ADMA in nephrology","volume":"3","author":"Kielstein","year":"2007","journal-title":"Nephrol Ther"},{"key":"2025071004061739300_bib21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1006\/bbrc.2000.3169","article-title":"Regulation of nitric oxide production by arginine metabolic enzymes","volume":"275","author":"Mori","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2025071004061739300_bib22","doi-asserted-by":"publisher","first-page":"1161761","DOI":"10.3389\/fcvm.2023.1161761","article-title":"Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score","volume":"10","author":"Dehghanbanadaki","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2025071004061739300_bib23","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ki.2008.638","article-title":"Factors other than glomerular filtration rate affect serum cystatin C levels","volume":"75","author":"Stevens","year":"2009","journal-title":"Kidney Int"},{"key":"2025071004061739300_bib24","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1681\/ASN.0000000000000147","article-title":"Validation of eGFR for detecting associations between serum protein biomarkers and subsequent GFR decline","volume":"34","author":"Enoksen","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2025071004061739300_bib25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1681\/ASN.2010050479","article-title":"Estimated GFR associates with cardiovascular risk factors independently of measured GFR","volume":"22","author":"Mathisen","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2025071004061739300_bib26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ncpneph0143","article-title":"Arginine, arginine analogs and nitric oxide production in chronic kidney disease","volume":"2","author":"Baylis","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"2025071004061739300_bib27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000371557","article-title":"Estimated GFR is biased by non-traditional cardiovascular risk factors","volume":"41","author":"Melsom","year":"2015","journal-title":"Am J Nephrol"},{"key":"2025071004061739300_bib28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ekir.2023.01.015","article-title":"Nitric oxide precursors and dimethylarginines as risk markers for accelerated measured GFR decline in the general population","volume":"8","author":"Rinde","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2025071004061739300_bib29","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1093\/ndt\/gfl292","article-title":"Symmetric dimethylarginine (SDMA) as endogenous marker of renal function\u2014a meta-analysis","volume":"21","author":"Kielstein","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"2025071004061739300_bib30","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ije\/dyr049","article-title":"Cohort profile: the Troms\u00f8 Study","volume":"41","author":"Jacobsen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"2025071004061739300_bib31","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/ckj\/sfw071","article-title":"Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: why to measure glomerular filtration rate with iohexol?","volume":"9","author":"Delanaye","year":"2016","journal-title":"Clin Kidney J"},{"key":"2025071004061739300_bib32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/HJH.0b013e32834f973a","article-title":"Ambulatory blood pressure is associated with measured glomerular filtration rate in the general middle-aged population","volume":"30","author":"Mathisen","year":"2012","journal-title":"J Hypertens"},{"key":"2025071004061739300_bib33","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2008.02.027","article-title":"Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: a gender-specific follow-up study","volume":"201","author":"Solbu","year":"2008","journal-title":"Atherosclerosis"},{"key":"2025071004061739300_bib34","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/ki.2010.321","article-title":"Cystatin C is not a better estimator of GFR than plasma creatinine in the general population","volume":"78","author":"Eriksen","year":"2010","journal-title":"Kidney Int"},{"key":"2025071004061739300_bib35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.kint.2024.06.029","article-title":"Iohexol plasma clearance measurement protocol standardization for adults: a consensus paper of the European Kidney Function Consortium","volume":"106","author":"Ebert","year":"2024","journal-title":"Kidney Int"},{"key":"2025071004061739300_bib36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1475-097X.1983.tb00712.x","article-title":"A method for the calculation of renal clearance based on a single plasma sample","volume":"3","author":"Jacobsson","year":"1983","journal-title":"Clin Physiol"},{"key":"2025071004061739300_bib37","first-page":"48","article-title":"Iohexol clearance for the determination of glomerular filtration rate: 15 years\u2019 experience in clinical practice","volume":"13","author":"Nilsson-Ehle","year":"2001","journal-title":"EJIFCC"},{"key":"2025071004061739300_bib38","first-page":"303","article-title":"A formula to estimate the approximate surface area if height and weight be known. 1916","volume":"5","author":"Du Bois","year":"1989","journal-title":"Nutrition"},{"key":"2025071004061739300_bib39","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/ije\/dyaa213","article-title":"Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations","volume":"50","author":"Tennant","year":"2021","journal-title":"Int J Epidemiol"},{"key":"2025071004061739300_bib40","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.3390\/ijms20153668","article-title":"Asymmetric (ADMA) and symmetric (SDMA) dimethylarginines in chronic kidney disease: a clinical approach","volume":"20","author":"Oliva-Damaso","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025071004061739300_bib41","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/antiox9090864","article-title":"Oxidative stress in cardiovascular diseases","volume":"9","author":"Dubois-Deruy","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"2025071004061739300_bib42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2125.2007.02990.x","article-title":"Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism","volume":"65","author":"Schwedhelm","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"2025071004061739300_bib43","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.clnu.2017.10.009","article-title":"Citrulline in health and disease. Review on human studies","volume":"37","author":"Papadia","year":"2018","journal-title":"Clin Nutr"},{"key":"2025071004061739300_bib44","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.17219\/acem\/150475","article-title":"Citrulline and long-term mortality in patients with cardiovascular disease","volume":"31","author":"Konieczny","year":"2022","journal-title":"Adv Clin Exp Med"},{"key":"2025071004061739300_bib45","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.jacc.2009.02.036","article-title":"Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk","volume":"53","author":"Tang","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2025071004061739300_bib46","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1681\/ASN.2005101119","article-title":"Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease","volume":"17","author":"Bode-B\u00f6ger","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2025071004061739300_bib47","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1093\/eurheartj\/ehx118","article-title":"Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease","volume":"38","author":"Zewinger","year":"2017","journal-title":"Eur Heart J"},{"key":"2025071004061739300_bib48","first-page":"79","article-title":"How to control confounding effects by statistical analysis","volume":"5","author":"Pourhoseingholi","year":"2012","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"2025071004061739300_bib49","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12889-017-4189-8","article-title":"The impact of non-response bias due to sampling in public health studies: a comparison of voluntary versus mandatory recruitment in a Dutch national survey on adolescent health","volume":"17","author":"Cheung","year":"2017","journal-title":"BMC Public Health"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf181\/63485308\/sfaf181.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/7\/sfaf181\/63485308\/sfaf181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/7\/sfaf181\/63485308\/sfaf181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:06:37Z","timestamp":1752134797000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf181\/8161692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf181","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,6,13]]},"article-number":"sfaf181"}}